- Zacks Small Cap Research•6 days ago
By Grant Zeng, CFA OTC:GOVX New CSO Appointed On December 14, 2016, GeoVax (OTC:GOVX) announced that the company has promoted Farshad Guirakhoo , PhD, to the role of Chief Scientific Officer (CSO), effective ...
- Marketwired•18 days ago
GeoVax Labs, Inc. , a biotechnology company developing human vaccines using its novel platform technology, today noted that its Chief Scientific Officer, Farshad Guirakhoo, PhD, has been featured in the ...
- Marketwired•28 days ago
GeoVax Labs, Inc. , a biotechnology company developing human vaccines, announced today the initiation of the next human clinical trial of GeoVax's preventive HIV vaccine, GOVX-B11. The Phase 1 trial is ...
GOVX : Summary for GEOVAX LABS INC COM STK USD0.01 - Yahoo Finance
GeoVax Labs, Inc. (GOVX)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.06 - 0.07|
|52 Week Range||0.05 - 0.11|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.79|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|